Story
WuXi Biologics Shares Rise Over 4% on Deal to Acquire Transcenta Facility

Shares of WuXi Biologics, a global contract research, development, and manufacturing organization (CRDMO), surged in Hong Kong trading after the company announced a deal to acquire a biopharmaceutical facility from Transcenta Holding.
Market Reaction
On August 7, WuXi Biologics' stock (02269.HK) climbed 4.25% to close at HK$43.14, with a trading turnover of HK$368 million, as reported by Zhitong Finance APP. The stock price increase followed the morning announcement of the planned acquisition.
Deal Details
In a statement released via its official channels, WuXi Biologics confirmed it had reached an agreement to purchase Transcenta's process development and production base located in Hangzhou, China. The transaction is expected to be completed in the third quarter of 2026.
The facility is a significant addition to WuXi Biologics' infrastructure:
Ad- It covers an area of over 10,000 square meters.
- It is equipped with capabilities for process development, drug substance manufacturing, and drug product (fill-finish) services.
Strategic Rationale
The acquisition is intended to enhance WuXi Biologics' integrated, end-to-end service capabilities to meet growing client demand for development and commercial-scale projects. The company noted the expansion is necessary to support its increasing project pipeline.
"The acquisition further enhances WuXi Biologics' end-to-end service capabilities," said Dr. Chris Chen, CEO of WuXi Biologics, in the announcement. "As the number of projects and commercialization demand continue to grow, we will continue to respond to the diverse needs of our customers with high quality and high efficiency."
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.